Which has stronger earnings & valuation, TFX or STE?

STERIS has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teleflex $2.13B 2.66 -$905.64M -$22.80 N/A STERIS $5.94B 3.50 $782.30M $7.93 26.89

Is TFX or STE more profitable?

STERIS has a net margin of 13.18% compared to Teleflex's net margin of -35.88%. STERIS's return on equity of 14.15% beat Teleflex's return on equity. Company Net Margins Return on Equity Return on Assets Teleflex -35.88% 13.29% 6.55% STERIS 13.18% 14.15% 9.52%

Does the media refer more to TFX or STE?

In the previous week, Teleflex and Teleflex both had 5 articles in the media. STERIS's average media sentiment score of 1.79 beat Teleflex's score of 0.11 indicating that STERIS is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral STERIS 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has higher valuation & earnings, TFX or GMED?

Globus Medical has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teleflex $2.13B 2.66 -$905.64M -$22.80 N/A Globus Medical $2.94B 3.87 $537.87M $4.30 19.46

Is TFX or GMED more profitable?

Globus Medical has a net margin of 18.92% compared to Teleflex's net margin of -35.88%. Globus Medical's return on equity of 13.46% beat Teleflex's return on equity. Company Net Margins Return on Equity Return on Assets Teleflex -35.88% 13.29% 6.55% Globus Medical 18.92% 13.46% 11.65%

Does the media refer more to TFX or GMED?

In the previous week, Globus Medical had 4 more articles in the media than Teleflex. MarketBeat recorded 9 mentions for Globus Medical and 5 mentions for Teleflex. Globus Medical's average media sentiment score of 1.08 beat Teleflex's score of 0.11 indicating that Globus Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Globus Medical 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BAX or TFX?

In the previous week, Teleflex had 3 more articles in the media than Baxter International. MarketBeat recorded 5 mentions for Teleflex and 2 mentions for Baxter International. Baxter International's average media sentiment score of 0.59 beat Teleflex's score of 0.11 indicating that Baxter International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teleflex 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, PODD or TFX?

Insulet has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Insulet $2.90B 3.77 $247.10M $4.30 36.68 Teleflex $2.13B 2.66 -$905.64M -$22.80 N/A

Is PODD or TFX more profitable?

Insulet has a net margin of 10.44% compared to Teleflex's net margin of -35.88%. Insulet's return on equity of 26.87% beat Teleflex's return on equity. Company Net Margins Return on Equity Return on Assets Insulet 10.44% 26.87% 12.01% Teleflex -35.88% 13.29% 6.55%

Does the media prefer PODD or TFX?

In the previous week, Insulet had 2 more articles in the media than Teleflex. MarketBeat recorded 7 mentions for Insulet and 5 mentions for Teleflex. Insulet's average media sentiment score of 0.72 beat Teleflex's score of 0.11 indicating that Insulet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Insulet 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teleflex 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, TFX or MASI?

Masimo has lower revenue, but higher earnings than Teleflex. Masimo is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teleflex $2.13B 2.66 -$905.64M -$22.80 N/A Masimo $1.56B 6.05 -$151.50M -$10.54 N/A

Is TFX or MASI more profitable?

Masimo has a net margin of 4.90% compared to Teleflex's net margin of -35.88%. Masimo's return on equity of 31.33% beat Teleflex's return on equity. Company Net Margins Return on Equity Return on Assets Teleflex -35.88% 13.29% 6.55% Masimo 4.90% 31.33% 13.93%

Does the media favor TFX or MASI?

In the previous week, Masimo had 1 more articles in the media than Teleflex. MarketBeat recorded 6 mentions for Masimo and 5 mentions for Teleflex. Masimo's average media sentiment score of 0.51 beat Teleflex's score of 0.11 indicating that Masimo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Masimo 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Teleflex (TFX) Competitors

$127.84 -2.02 (-1.56%)

Closing price 06/29/2026 03:59 PM Eastern

Extended Trading

$126.88 -0.96 (-0.75%)

As of 03:59 AM Eastern

Compare

TFX vs. STE, GMED, BAX, PODD, and MASI

Should you buy Teleflex stock or one of its competitors? MarketBeat compares Teleflex with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Teleflex include STERIS (STE), Globus Medical (GMED), Baxter International (BAX), Insulet (PODD), and Masimo (MASI). These companies are all part of the "health care equipment" industry.

How does Teleflex compare to STERIS?

Teleflex (NYSE:TFX) and STERIS (NYSE:STE) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.1%. STERIS pays an annual dividend of $2.52 per share and has a dividend yield of 1.2%. Teleflex pays out -6.0% of its earnings in the form of a dividend. STERIS pays out 31.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS has raised its dividend for 20 consecutive years. STERIS is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 94.7% of STERIS shares are owned by institutional investors. 0.7% of Teleflex shares are owned by company insiders. Comparatively, 1.1% of STERIS shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

STERIS has a net margin of 13.18% compared to Teleflex's net margin of -35.88%. STERIS's return on equity of 14.15% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
STERIS	13.18%	14.15%	9.52%

Teleflex has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, STERIS has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market.

In the previous week, Teleflex and Teleflex both had 5 articles in the media. STERIS's average media sentiment score of 1.79 beat Teleflex's score of 0.11 indicating that STERIS is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
STERIS	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Teleflex currently has a consensus target price of $146.00, suggesting a potential upside of 14.21%. STERIS has a consensus target price of $278.00, suggesting a potential upside of 30.39%. Given STERIS's stronger consensus rating and higher probable upside, analysts plainly believe STERIS is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30
STERIS	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

STERIS has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$2.13B	2.66	-$905.64M	-$22.80	N/A
STERIS	$5.94B	3.50	$782.30M	$7.93	26.89

Summary

STERIS beats Teleflex on 15 of the 18 factors compared between the two stocks.

How does Teleflex compare to Globus Medical?

Teleflex (NYSE:TFX) and Globus Medical (NYSE:GMED) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.

Globus Medical has a net margin of 18.92% compared to Teleflex's net margin of -35.88%. Globus Medical's return on equity of 13.46% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
Globus Medical	18.92%	13.46%	11.65%

In the previous week, Globus Medical had 4 more articles in the media than Teleflex. MarketBeat recorded 9 mentions for Globus Medical and 5 mentions for Teleflex. Globus Medical's average media sentiment score of 1.08 beat Teleflex's score of 0.11 indicating that Globus Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Globus Medical	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 18.4% of Globus Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Teleflex has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, suggesting that its share price is 5% less volatile than the broader market.

Teleflex presently has a consensus target price of $146.00, suggesting a potential upside of 14.21%. Globus Medical has a consensus target price of $105.00, suggesting a potential upside of 25.47%. Given Globus Medical's stronger consensus rating and higher probable upside, analysts clearly believe Globus Medical is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30
Globus Medical	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.87

Globus Medical has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$2.13B	2.66	-$905.64M	-$22.80	N/A
Globus Medical	$2.94B	3.87	$537.87M	$4.30	19.46

Summary

Globus Medical beats Teleflex on 16 of the 17 factors compared between the two stocks.

How does Teleflex compare to Baxter International?

Baxter International (NYSE:BAX) and Teleflex (NYSE:TFX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

In the previous week, Teleflex had 3 more articles in the media than Baxter International. MarketBeat recorded 5 mentions for Teleflex and 2 mentions for Baxter International. Baxter International's average media sentiment score of 0.59 beat Teleflex's score of 0.11 indicating that Baxter International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Baxter International has a net margin of -9.70% compared to Teleflex's net margin of -35.88%. Baxter International's return on equity of 16.15% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.70%	16.15%	5.24%
Teleflex	-35.88%	13.29%	6.55%

Baxter International has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market.

Baxter International currently has a consensus price target of $19.73, indicating a potential downside of 10.36%. Teleflex has a consensus price target of $146.00, indicating a potential upside of 14.21%. Given Teleflex's stronger consensus rating and higher probable upside, analysts plainly believe Teleflex is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30

Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.1%. Baxter International pays out -1.9% of its earnings in the form of a dividend. Teleflex pays out -6.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teleflex is clearly the better dividend stock, given its higher yield and lower payout ratio.

90.2% of Baxter International shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 0.2% of Baxter International shares are held by insiders. Comparatively, 0.7% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Teleflex has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.01	-$957M	-$2.13	N/A
Teleflex	$2.13B	2.66	-$905.64M	-$22.80	N/A

Summary

Teleflex beats Baxter International on 13 of the 18 factors compared between the two stocks.

How does Teleflex compare to Insulet?

Insulet (NASDAQ:PODD) and Teleflex (NYSE:TFX) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

In the previous week, Insulet had 2 more articles in the media than Teleflex. MarketBeat recorded 7 mentions for Insulet and 5 mentions for Teleflex. Insulet's average media sentiment score of 0.72 beat Teleflex's score of 0.11 indicating that Insulet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Insulet has a net margin of 10.44% compared to Teleflex's net margin of -35.88%. Insulet's return on equity of 26.87% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	10.44%	26.87%	12.01%
Teleflex	-35.88%	13.29%	6.55%

Insulet has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.90B	3.77	$247.10M	$4.30	36.68
Teleflex	$2.13B	2.66	-$905.64M	-$22.80	N/A

95.6% of Teleflex shares are held by institutional investors. 0.4% of Insulet shares are held by insiders. Comparatively, 0.7% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Insulet presently has a consensus price target of $238.67, suggesting a potential upside of 51.30%. Teleflex has a consensus price target of $146.00, suggesting a potential upside of 14.21%. Given Insulet's stronger consensus rating and higher probable upside, analysts plainly believe Insulet is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	2 Sell rating(s)	4 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.71
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30

Insulet has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Summary

Insulet beats Teleflex on 14 of the 16 factors compared between the two stocks.

How does Teleflex compare to Masimo?

Teleflex (NYSE:TFX) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership.

Teleflex presently has a consensus price target of $146.00, suggesting a potential upside of 14.21%. Masimo has a consensus price target of $180.40, suggesting a potential upside of 0.25%. Given Teleflex's stronger consensus rating and higher probable upside, equities analysts plainly believe Teleflex is more favorable than Masimo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30
Masimo	0 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

95.6% of Teleflex shares are held by institutional investors. Comparatively, 86.0% of Masimo shares are held by institutional investors. 0.7% of Teleflex shares are held by insiders. Comparatively, 9.7% of Masimo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Teleflex has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, Masimo has a beta of 1.11, indicating that its share price is 11% more volatile than the broader market.

In the previous week, Masimo had 1 more articles in the media than Teleflex. MarketBeat recorded 6 mentions for Masimo and 5 mentions for Teleflex. Masimo's average media sentiment score of 0.51 beat Teleflex's score of 0.11 indicating that Masimo is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Masimo	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Masimo has a net margin of 4.90% compared to Teleflex's net margin of -35.88%. Masimo's return on equity of 31.33% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
Masimo	4.90%	31.33%	13.93%

Masimo has lower revenue, but higher earnings than Teleflex. Masimo is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$2.13B	2.66	-$905.64M	-$22.80	N/A
Masimo	$1.56B	6.05	-$151.50M	-$10.54	N/A

Summary

Masimo beats Teleflex on 10 of the 16 factors compared between the two stocks.

Get Teleflex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TFX vs. The Competition

Export

Metric	Teleflex	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$5.64B	$7.36B	$6.84B	$23.30B
Dividend Yield	1.05%	1.24%	2.66%	4.07%
P/E Ratio	-5.61	51.01	25.79	31.77
Price / Sales	2.66	83.88	539.82	111.62
Price / Cash	11.60	26.99	29.09	18.60
Price / Book	1.81	7.63	10.88	4.78
Net Income	-$905.64M	$159.19M	$3.57B	$1.07B
7 Day Performance	3.05%	2.17%	2.47%	1.43%
1 Month Performance	-0.75%	-3.34%	0.84%	0.75%
1 Year Performance	8.15%	6.03%	36.37%	25.24%

Teleflex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TFX Teleflex	3.5767 of 5 stars	$127.84 -1.6%	$146.00 +14.2%	+7.0%	$5.64B	$2.13B	N/A	15,500	Analyst Upgrade
STE STERIS	4.8497 of 5 stars	$202.59 0.0%	$278.00 +37.2%	-10.7%	$19.75B	$5.94B	25.55	17,937	Positive News
GMED Globus Medical	4.6703 of 5 stars	$79.12 -0.1%	$105.00 +32.7%	+43.0%	$10.76B	$2.94B	18.40	6,000	Positive News High Trading Volume
BAX Baxter International	1.3935 of 5 stars	$19.92 +0.2%	$19.73 -1.0%	-27.7%	$10.27B	$11.32B	N/A	37,500
PODD Insulet	4.4659 of 5 stars	$145.76 flat	$240.78 +65.2%	-49.6%	$10.10B	$2.71B	33.90	5,400	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TFX) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Teleflex (TFX) Competitors